We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test Could Detect Infection Exposure History

By LabMedica International staff writers
Posted on 02 Feb 2026

Every infection leaves a lasting imprint on the immune system, but current diagnostic tools can usually detect exposure to only one pathogen at a time. More...

This makes it difficult to understand a person’s full infection history or immune protection using a simple test. Because immune responses vary widely between individuals, this diagnostic potential remains largely untapped. Researchers are now working toward a blood-based approach that could reconstruct lifelong exposure to infections by reading immune cell signatures.

T-cells detect infections through highly specific surface sensors known as T-cell receptors, each designed to bind a particular antigen. When a matching antigen is encountered, the corresponding T-cells multiply rapidly. While most die after clearing the infection, a subset remains as memory T-cells, preserving a record of that encounter. Researchers at the University of Erlangen-Nuremberg (FAU, Erlangen, Germany), in collaboration with the University Hospital Erlangen (Erlangen, Germany), have shown that exposure to a pathogen leads to the expansion of many T-cell clones, creating detectable patterns in the blood.

Although individual T-cell receptors differ greatly between people, infections often generate shared or even identical receptor sequences across multiple individuals. These recurring patterns form what researchers describe as an immunological fingerprint. By comparing T-cell receptor sequences from individuals with confirmed past infections, the team aims to identify receptor features specific to particular pathogens. Machine learning algorithms will be used to analyze these large datasets and link receptor patterns to known infectious diseases.

The researchers are initially focusing on viruses that can cause complications during pregnancy, such as rubella. One goal is to assess whether vaccinated or previously infected individuals, including pregnant women, still retain protective immunity by analyzing their T-cell profiles. This approach could complement or even extend beyond traditional antibody-based serological tests. In the long term, the team plans to build libraries of pathogen-specific T-cell receptors and contribute to a global database. This could allow a single blood test to provide a comprehensive overview of an individual’s infection history and immune status across their lifetime.

“Each infection leaves a trace in the immune system. For example, if you have ever had the flu, you will have more T-cells whose receptors match the flu virus antigens than someone who has not.” said Professor Kilian Schober, PhD, lead investigator. “In future, a single test may be sufficient to illustrate an individual’s infection history over their entire lifetime.”

Related Links:
FAU
University Hospital Erlangen


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.